BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23393394)

  • 1. MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome.
    Hutcheson R; Terry R; Chaplin J; Smith E; Musiyenko A; Russell JC; Lincoln T; Rocic P
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):727-36. PubMed ID: 23393394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction.
    Joseph G; Soler A; Hutcheson R; Hunter I; Bradford C; Hutcheson B; Gotlinger KH; Jiang H; Falck JR; Proctor S; Schwartzman ML; Rocic P
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H528-H540. PubMed ID: 28011587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-21 normalizes vascular smooth muscle proliferation and improves coronary collateral growth in metabolic syndrome.
    Hutcheson R; Chaplin J; Hutcheson B; Borthwick F; Proctor S; Gebb S; Jadhav R; Smith E; Russell JC; Rocic P
    FASEB J; 2014 Sep; 28(9):4088-99. PubMed ID: 24903275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-21-mediated decreased neutrophil apoptosis is a determinant of impaired coronary collateral growth in metabolic syndrome.
    Hutcheson R; Terry R; Hutcheson B; Jadhav R; Chaplin J; Smith E; Barrington R; Proctor SD; Rocic P
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1323-35. PubMed ID: 25840830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.
    Dodd T; Wiggins L; Hutcheson R; Smith E; Musiyenko A; Hysell B; Russell JC; Rocic P
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1339-49. PubMed ID: 23599440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin type I receptor blockade in conjunction with enhanced Akt activation restores coronary collateral growth in the metabolic syndrome.
    Jadhav R; Dodd T; Smith E; Bailey E; Delucia AL; Russell JC; Madison R; Potter B; Walsh K; Jo H; Rocic P
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1938-49. PubMed ID: 21335466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-sensitive Akt and Src regulate coronary collateral growth in metabolic syndrome.
    Reed R; Potter B; Smith E; Jadhav R; Villalta P; Jo H; Rocic P
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1811-21. PubMed ID: 19376806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Platelet miR-223 Induction in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis.
    Zhang Y; Wang Y; Zhang L; Xia L; Zheng M; Zeng Z; Liu Y; Yarovinsky T; Ostriker AC; Fan X; Weng K; Su M; Huang P; Martin KA; Hwa J; Tang WH
    Circ Res; 2020 Sep; 127(7):855-873. PubMed ID: 32597702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
    Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
    Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of vascular progenitor cells from endothelial cells stimulates coronary collateral growth.
    Yin L; Ohanyan V; Pung YF; Delucia A; Bailey E; Enrick M; Stevanov K; Kolz CL; Guarini G; Chilian WM
    Circ Res; 2012 Jan; 110(2):241-52. PubMed ID: 22095729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
    Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt modulation by miR-145 during exercise-induced VSMC phenotypic switching in hypertension.
    Liao J; Zhang Y; Wu Y; Zeng F; Shi L
    Life Sci; 2018 Apr; 199():71-79. PubMed ID: 29522767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G6PD activity contributes to the regulation of histone acetylation and gene expression in smooth muscle cells and to the pathogenesis of vascular diseases.
    Dhagia V; Kitagawa A; Jacob C; Zheng C; D'Alessandro A; Edwards JG; Rocic P; Gupte R; Gupte SA
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H999-H1016. PubMed ID: 33416454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Complement 3 With Suppression of miR-145 Induces the Synthetic Phenotype in Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats.
    Chen L; Fukuda N; Otsuki T; Tanaka S; Nakamura Y; Kobayashi H; Matsumoto T; Abe M
    J Am Heart Assoc; 2019 May; 8(10):e012327. PubMed ID: 31070083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of coronary collateral growth in the Zucker obese rat: impact of VEGF and ecSOD.
    Hattan N; Chilian WM; Park F; Rocic P
    Basic Res Cardiol; 2007 May; 102(3):217-23. PubMed ID: 17323199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic switching of vascular smooth muscle cells in the 'normal region' of aorta from atherosclerosis patients is regulated by miR-145.
    Zhang YN; Xie BD; Sun L; Chen W; Jiang SL; Liu W; Bian F; Tian H; Li RK
    J Cell Mol Med; 2016 Jun; 20(6):1049-61. PubMed ID: 26992033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial-derived extracellular microRNA-92a promotes arterial stiffness by regulating phenotype changes of vascular smooth muscle cells.
    Wang C; Wu H; Xing Y; Ye Y; He F; Yin Q; Li Y; Shang F; Shyy JY; Yuan ZY
    Sci Rep; 2022 Jan; 12(1):344. PubMed ID: 35013491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the Ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia.
    Dong LH; Wen JK; Liu G; McNutt MA; Miao SB; Gao R; Zheng B; Zhang H; Han M
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):683-91. PubMed ID: 20139360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
    Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation.
    Wang YS; Wang HY; Liao YC; Tsai PC; Chen KC; Cheng HY; Lin RT; Juo SH
    Cardiovasc Res; 2012 Sep; 95(4):517-26. PubMed ID: 22802111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.